This Solicitation opportunity from Department Of Defense was posted on September 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

SODIUM CHLORIDE INJECT

Closed

SPE2DP-26-T-5025Federal

Submission Closed09/21/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supplier of Pre-mixed Ophthalmic Saline SolutionThis subcontract opportunity with the Department of Defense Medical Supply Chain Pharm FSA involves the supply of pre-mixed, preserved, buffered, and pH-balanced saline ophthalmic solution. The required product must be compatible with Porta Stream I, II, and III portable eyewash stations, specifically matching NSN 6505-01-354-4551 and provided in 1-gallon bottles. All supplies must adhere to Medical Marking Standard No. 1 and the DLA Master List of Technical and Quality Requirements. The contract requires the delivery of four packages of saline solution, each maintaining a minimum shelf life of 26 months. Performance will take place at FPO 96370-0060 under NAICS code 325412. Interested parties must respond by November 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Pharmaceutical Lidocaine HClThis subcontract involves the supply of pharmaceutical-grade 1% Lidocaine HCl in 5ml ampules to prime contractors supporting Department of Defense medical supply contracts. Managed by the Medical Supply Chain MD Surg FSF, the agreement mandates that all products maintain strict pharmaceutical-grade purity and sterile packaging. To ensure safety and efficacy, the provider must hold valid FDA approval for pharmaceutical manufacturing and strictly adhere to established shelf-life requirements. The contract focuses on the bulk delivery of ampules to the prime contractor, with the place of performance located at FPO 96667. Identified under NAICS code 325412, the solicitation was posted on November 3, 2026, with a response deadline of November 9, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Atropine Sulfate Injection ManufacturingThis subcontract involves the manufacturing of Atropine Sulfate Injection for prime contractors supporting Department of Defense Medical Supply Chain projects. The required product must be sterile, nonpyrogenic, preservative-free, and non-DEHP, formulated with 0.1 mg/ml atropine sulfate monohydrate and 9 mg sodium chloride per ml in 5 ml units. All finished units must meet USP specifications and be produced within a cleanroom environment in strict compliance with FDA CGMP standards. The project falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance of the contract is designated for Fort Bragg, North Carolina. Interested parties must adhere to the response deadline of November 9, 2026, to provide the specified medical supplies under NSN 6505-01-573-1657.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

OEM Manufacturer of Ethyl Alcohol Hand SanitizerThis subcontract involves the OEM manufacture and supply of finished, bottled hand sanitizer for prime contractors supporting the Department of Defense Medical Supply Chain. The required product is an unscented, waterless cleanser featuring a 70% ethyl alcohol base, packaged in 4 fl oz containers and distributed in units of 24. All deliverables must maintain a 36-month shelf life and strictly adhere to Medical Marking Standard No. 1 and MIL-STD-2073-1E. The contract mandates full compliance with the Buy American Act and falls under NAICS code 325412. Performance for this requirement is centered in Johnston, Iowa. Interested parties must note the response deadline of November 9, 2026, to provide the specified medical-grade sanitizing supplies.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Lidocaine 4% Gel with Aloe VeraThis subcontract through the Medical Supply Chain Pharm FSA for the Department of Defense involves the supply of Lidocaine 4% Gel with Aloe Vera. The contract requires the delivery of fragrance-free 4oz containers provided in boxes of 12, specifically formulated for pain relief. All products must adhere to strict quality and regulatory standards, including FDA regulations, Medical Marking Standard No. 1, MIL-STD-2073-1E, and RP001 packaging requirements. The supplier must ensure a shelf-life of 24 months and maintain storage temperatures below 100 degrees Fahrenheit. This opportunity is categorized under NAICS code 325412, with the place of performance located at FPO 96671-4077. The response deadline for this requirement is November 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Artificial Tears Solution (NSN 6505009617486)This subcontract involves the supply of FDA-regulated Artificial Tears Solution, 1.4%, in 15 ML bottles for the Department of Defense Medical Supply Chain Pharm FSA. The selected supplier is responsible for manufacturing or sourcing the pharmaceutical formulation using FDA-approved facilities and sterile equipment to ensure a non-extendable shelf life of 36 months. The contract requires the delivery of 62 bottles and mandates strict compliance with the Buy American Act and the Berry Amendment. The project falls under NAICS code 325412 and is managed by DLA Troop Support. Performance will take place at FPO 96694-1500. Interested parties must adhere to the timeline established by the posting date of November 3, 2026, with a response deadline of November 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Povidone-Iodine Solution SupplierThis subcontract involves the supply of active chemical antiseptic solution to prime contractors supporting the Department of Defense Medical Supply Chain. The selected supplier is responsible for the chemical synthesis and formulation of Povidone-Iodine solution, ensuring a precise 1% titratable iodine concentration. All bulk deliveries must be accompanied by Certificates of Analysis to verify purity and concentration levels. Strict adherence to regulatory standards is required, including FDA and pharmaceutical grade certifications. Additionally, the supplier must comply with the Buy American Act and the Berry Amendment. Performance for this contract is centered in Pensacola, Florida, under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

SALINE FOR OPHTHALMIC

Solicitation # SPE2DP-27-T-0228

Solicitation SPE2DP-27-T-0228 is for the procurement of pre-mixed, preserved, buffered, and pH-balanced saline ophthalmic solution (NSN 6505-01-354-4551) for use with Porta Stream I, II, and III portable eyewash stations. The requirement consists of four packages, each containing four 1-gallon bottles. The product must have a total shelf life of 30 months, with a minimum of 26 months remaining upon receipt. Delivery is required within five days of award, with a destination delivery date of November 4, 2026, shipping to the Naval Mobile Construction Battalion at Camp Shields in Okinawa, Japan. The contract mandates strict adherence to the DLA Master List of Technical and Quality Requirements, specifically RP001 for packaging and RA001 for quality standards. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial per ASTM D3951 unless the material is deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies. Invoicing and payment must be processed through the Wide Area WorkFlow (WAWF) system. This is not a small business set-aside, and the procurement is governed by NAICS code 325412, incorporating various DFARS and FAR clauses regarding cybersecurity, the Buy American Act, and hazardous material identification.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-27-T-0230

Solicitation SPE2DP-27-T-0230 is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Artificial Tears Solution, 1.4%, in 15 ML bottles under NSN 6505009617486. The requirement consists of three line items totaling 62 bottles, with individual quantities of 10, 2, and 50 units. This FDA-regulated medical product is a Type I Code Q item with a non-extendable shelf life of 36 months. Delivery is required within 5 days of order, with FOB Destination terms. Shipments are directed to multiple locations, including the USS Rafael Peralta DDG 115, Joint Base Anacostia, and Shreveport, Louisiana. The contract mandates strict adherence to DLA packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial per ASTM D3951 unless the material is deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies. Palletization must follow RP001 guidelines. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and cybersecurity protections for covered defense information. Quotations must be submitted via the DIBBS portal by November 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0233

Solicitation SPE2DP-27-T-0233, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of Dibucaine Ointment, USP. The required product is a rectal ointment containing 1 percent dibucaine as the active ingredient, supplied in a collapsible tube with a rectal applicator. Each unit of issue consists of one package containing one ounce or 28 grams. The product must be stored between 15 and 30 degrees Celsius and is intended for external, rectal administration. The procurement specifies a quantity of one package with a required delivery date of November 5, 2026, and a delivery lead time of 20 days after order. The contract mandates strict adherence to quality and packaging standards, including USP standards, MIL-STD-129 for marking, and Medical Marking Standard No. 1. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, while hazardous materials must follow TQ requirement IP025 and FED-STD-313. Delivery is FOB Destination, with inspection and acceptance also occurring at the destination. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow (WAWF) system. Key regulatory and legal requirements include compliance with the Buy American Act, the Berry Amendment, and DFARS regulations regarding the safeguarding of covered defense information and the prohibition of certain telecommunications equipment. Offerors must be registered in the System for Award Management (SAM) and provide necessary representations and certifications regarding their business size and socioeconomic status. Quotations are to be submitted via the DIBBS portal by November 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0229

Solicitation SPE2DP-27-T-0229 is a procurement by the Defense Logistics Agency for one 100 gram bottle of Sodium Perborate in powder form, identified by NSN 6505-01-307-3268. The item is a regulated FDA drug or device and is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Strict storage requirements apply, including avoiding high humidity and maintaining temperatures below 32 degrees Celsius (90 degrees Fahrenheit), while keeping the material away from flammable or combustible substances. Delivery is required within 20 days after receipt of order, with a destination FOB and a required delivery date of August 6, 2026, for shipment to the USS Portland LPD 27 via DLA Distribution San Diego. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for material marking. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, though TQ requirement IP025 and FED-STD-313 apply if the material is deemed hazardous. Inspection and acceptance will occur at the destination per FAR 52.246-2. The procurement incorporates various federal and defense clauses, including the Buy American Act, DFARS cybersecurity reporting requirements, and the DLA Master List of Technical and Quality Requirements. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Generic Pharmaceutical Product SupplierThis subcontract opportunity with NHS England seeks a supplier of generic pharmaceutical medications to support prime contractors on Project Revive. The selected provider will be responsible for the manufacture or wholesale of generic drugs, ensuring all products meet pharmaceutical grade quality and adhere to UK health standards for packaging and labeling. Deliveries must be made to designated NHS purchasing points. To qualify, suppliers must possess the necessary infrastructure, including pharmaceutical manufacturing facilities, cold chain storage, and GDP compliant warehouses. Mandatory certifications include MHRA licensing, as well as GMP and GDP certifications. Interested parties must submit their responses by November 30, 2026.

NHS England

POSTED

about 14 hours ago

DEADLINE

in 26 days

AI Contract Overview

Solicitation SPE2DP-26-T-5025 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Sodium Chloride 0.9% Injection, USP, 250 ML. The requirement consists of two packages, with each package containing 24 bags. The product is regulated by the FDA and must adhere to USP standards, with a non-extendable shelf life of 24 months. Delivery is required within 20 days after order, with the destination for delivery, inspection, and acceptance set as Fort Campbell, Kentucky. The contractor must comply with strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129, and MIL-STD-2073-1E. Storage requirements specify a recommended room temperature of 25 degrees Celsius, with protection from freezing and excessive heat. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and adherence to the Buy American Act and Berry Amendment. The solicitation also incorporates the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105 and requires compliance with DFARS 252.204-7012 regarding the safeguarding of covered defense information.

General Info

Fixed-price procurement of Sodium Chloride 0.9% injections for delivery to Fort Campbell.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

BLDG 5505A WICKHAM AVE, FORT CAMPBELL, KY, 42223-5000, USA

Set-Aside

NONE

Documents

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedSep 13

Solicitation

Response DeadlineSep 21

Deadline has passed

Submission Closed

09/21/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

JAMES FOGGIE

contact@example.gov

+1 (555) 000-0000

Full Description

SODIUM CHLORIDE INJECTION
SODIUM CHLORIDE 0.9% INJECTION, USP, 250 ML, 24S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 24 EA RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SPE2DP-26-T-5025
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); However, brief exposure up to 40°C does not adversely affect the product B.BRAUN MCGAW NDC00264-7800-20 U/I "PG" (24 BAGS) SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
TRILLAMED LLC 56FN2 P/N TM-L8002 TRILLAMED LLC 56FN2 P/N TM-NDC00264-7800-20 B. BRAUN MEDICAL INC 11171 P/N L8002 B. BRAUN MEDICAL INC 11171 P/N NDC00264-7800-20 CARDINAL HEALTH 200, LLC 07TA6 P/N TML8002 OWENS & MINOR DISTRIBUTION INC 9C381 P/N 32180798302 ICU MEDICAL, INC. 1RNZ0 P/N NDC00990-7983-02
TDP Rev A Gen 1 IAW REFERENCE REVISION NR DTD PART PIECE NUMBER:
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018267299 0001 PG 2.000
NSN/MATERIAL:6505013318945
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-331-8945 Quantity: 2 PG Purchase Request: 7018267299QTY: 2 Delivery: 20 days ADO